Directed new share issue in InDex Pharmaceuticlas Holding AB (SE) — SEK 140 million Healthcare Directed new share issue in InDex Pharmaceuticlas Holding AB (SE) — SEK 140 million
Placing of shares in Stillfront AB (SE) — SEK 750 million TMT Placing of shares in Stillfront AB (SE) — SEK 750 million
Senior secured financing for DBT Capital INV AB (SE) — SEK 400 million FIG Senior secured financing for DBT Capital INV AB (SE) — SEK 400 million
Subordinated Tier 2 bonds by Qliro Financial Services (SE) — SEK 100 million FIG Subordinated Tier 2 bonds by Qliro Financial Services (SE) — SEK 100 million
Placing of shares in Lime Technologies AB (SE) — SEK 165 million TMT Placing of shares in Lime Technologies AB (SE) — SEK 165 million
Sale of Svedea AB (SE) to HDI Global Specialty SE (DE) — Amount not disclosed FIG Sale of Svedea AB (SE) to HDI Global Specialty SE (DE) — Amount not disclosed
Divestment of NRC Holding Design OY (FI) to Sweco AB (SE) by NRC Group Holding AS (NO) — Enterprise value EUR 42.5 million Business Services Divestment of NRC Holding Design OY (FI) to Sweco AB (SE) by NRC Group Holding AS (NO) — Enterprise value EUR 42.5 million
Directed new share issue in Calliditas Therapeutics (SE) — SEK 210 million Healthcare Directed new share issue in Calliditas Therapeutics (SE) — SEK 210 million
Private placement of shares in Klarna Holding AB (SE) — USD 460 million FIG Private placement of shares in Klarna Holding AB (SE) — USD 460 million
Senior secured financing and subordinated loan for Ovzon AB (SE) — USD 60 millon & SEK 200 million TMT Senior secured financing and subordinated loan for Ovzon AB (SE) — USD 60 millon & SEK 200 million
Divestment of majority stake in Arc E-commerce AB (SE) to Bygghemma Group AB (SE) — Amount not disclosed Consumer & Retail Divestment of majority stake in Arc E-commerce AB (SE) to Bygghemma Group AB (SE) — Amount not disclosed
Directed new share issue in Oncopeptides AB (SE) — SEK 727 million Healthcare Directed new share issue in Oncopeptides AB (SE) — SEK 727 million